|
MRPL23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.348400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.678200E-01 |
| Normal-vs-Stage2 |
2.585600E-01 |
| Normal-vs-Stage3 |
4.168600E-01 |
| Normal-vs-Stage4 |
4.979600E-01 |
| Stage1-vs-Stage2 |
5.971600E-01 |
| Stage1-vs-Stage3 |
8.693400E-01 |
| Stage1-vs-Stage4 |
7.570000E-01 |
| Stage2-vs-Stage3 |
5.282000E-01 |
| Stage2-vs-Stage4 |
5.075000E-01 |
| Stage3-vs-Stage4 |
8.997200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.151800E-01 |
| Normal-vs-AfricanAmerican |
2.759000E-01 |
| Normal-vs-Asian |
2.876400E-01 |
| Caucasian-vs-AfricanAmerican |
6.738200E-01 |
| Caucasian-vs-Asian |
7.190200E-01 |
| AfricanAmerican-vs-Asian |
8.841800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.302840E-01 |
| Normal-vs-Female |
3.596000E-01 |
| Male-vs-Female |
3.021200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.584210E-01 |
| Normal-vs-Age(41-60Yrs) |
3.819000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.647400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.258600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.368800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.500600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.205200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.849200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.575600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.868200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.930800E-01 |
| Classical-VS-Follicular |
8.702100E-03 |
| Classical-VS-Other |
2.738200E-01 |
| Classical-VS-Normal |
7.417800E-01 |
| Tall-VS-Follicular |
5.107800E-02 |
| Tall-VS-Other |
3.012200E-01 |
| Tall-VS-Normal |
7.678000E-01 |
| Follicular-VS-Other |
9.333600E-01 |
| Follicular-VS-Normal |
1.966160E-02 |
| Other-VS-Normal |
2.134600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.875600E-02 |
| Normal-vs-N1 |
3.815700E-02 |
| N0-vs-N1 |
3.176800E-01 |
|
|
